![](https://www.microbiometimes.com/wp-content/uploads/2024/06/Screenshot-2024-06-06-at-15.18.42-326x245.png)
Seres Therapeutics Enters Into Memorandum Of Understanding For Vowst™ Asset Sale To Nestlé Health Science
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide […]